JP MORGAN/PUT/BECTON DICKINSON AND CO./215/0.1/19.07.24 Share Price

Warrant

DE000JT1P9G5

Market Closed - Bid/Ask 08:21:44 27/06/2024 BST After market 19:15:36
0.12 EUR +9.09% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./215/0.1/19.07.24 0.195 +62.50%
Current month-77.55%
Date Price Change
27/06/24 0.12 +9.09%
26/06/24 0.11 +37.50%
25/06/24 0.08 +14.29%
24/06/24 0.07 -18.60%
21/06/24 0.086 -38.57%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 08:21 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JT1P9G
ISINDE000JT1P9G5
Date issued 30/05/2024
Strike 215 $
Maturity 19/07/2024 (22 Days)
Parity 10 : 1
Emission price 0.24
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.68
Lowest since issue 0.07
Delta-0.17x
Omega 22.36
Premium7.56x
Gearing130.6x
Moneyness 0.9320
Difference Strike -14.37 $
Difference Strike %-6.68%
Spread 0.03
Spread %16.67%
Theoretical value 0.1650
Implied Volatility 32.99 %
Total Loss Probability 80.85 %
Intrinsic value 0.000000
Present value 0.1650
Break even 213.23 €
Theta-0.07x
Vega0.01x
Rho-0x

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
231.6 USD
Average target price
279.2 USD
Spread / Average Target
+20.54%
Consensus